Clinical Trials Sponsored by hVIVO Services Limited

Total 53 results

Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Recruiting

A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection in a Virus Challenge Model

RSV Infection

United Kingdom
Enanta Pharmaceuticals, Inc
hVIVO Services Limited

Completed

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

RSV Infection

United Kingdom
Cocrystal Pharma, Inc.
hVIVO Services Limited

Recruiting

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

Influenza A

United Kingdom
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Healthy Subjects

Influenza A H3N2

United Kingdom
Prep Biopharm Limited
Hvivo

Completed

A Study to Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16

Viral Upper Respiratory Tract Infection

United Kingdom
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Subjects With Asthma

Asthma
International Stemcell Services Limited

Unknown

Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure

Chronic Renal Failure

India
International Stemcell Services Limited

Unknown

Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Osteoarthritis

Osteoarthritis

India
International Stemcell Services Limited

Completed

Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury (ABMST-SCI)

Spinal Cord Injuries

India
MGB Biopharma Limited
Hammersmith Medicines Research; Innovate UK; Cambridge Regulatory Services; Phases... and other collaborators

Completed

Safety, Blood Levels and Effects of MGB-BP-3

Healthy
RAI Services Company
Inflamax Research Limited

Completed

CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products

Tobacco Use

United States
RAI Services Company
Inflamax Research Limited

Completed

CSD170202: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products

Tobacco Use

United States
ImmunoBiology Limited
Simbec Research; ORION Clinical Services; Oxford Therapeutics Consulting Limited

Completed

A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax

Pneumococcal Infection

United Kingdom
Medical Developments International Limited
ORION Clinical Services

Completed

Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma (STOP!)

Acute Pain Due to Trauma

United Kingdom
RAI Services Company
ICON Clinical Research Limited

Completed

CSD1805: Study to Assess Nicotine Uptake and Product Use Behavior in Moist Snuff Consumers Using Two Moist Snuff Products

Tobacco Use

United States
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Withdrawn

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Plaque Psoriasis
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Terminated

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Atopic Dermatitis

United States
Bionomics Limited
CPR Pharma Services Pty Ltd, Australia

Terminated

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer

Australia
Dr. Reddy's Laboratories Limited
Novum Pharmaceutical Research Services

Completed

A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies

Scabies

United States, El Salvador, Panama
Vaccitech (UK) Limited
Clinical Network Services (CNS) Pty Ltd

Terminated

Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults

Influenza

Australia
South Metropolitan Health Service
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients (ZiPUP)

Urothelial Carcinoma

Australia
University of Minnesota
Neuromod Devices Limited; Kent Taylor

Active, not recruiting

Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus

Tinnitus

United States
Dr. Reddy's Laboratories Limited
Reliance Clinical Research Services (Navi Mumbai, India)

Completed

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Clostridium Difficile Associated Diarrhea

India
Nova Laboratories Limited
Syne Qua Non Limited; Medicines Evaluation Unit Ltd; Alderley Analytical Ltd; Black... and other collaborators

Completed

Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®) (AZA)

Therapeutic Equivalency

United Kingdom
Celtaxsys, Inc.
Clinical Network Services (CNS) Pty Ltd; Celtaxsys Aus Pty Limited

Completed

CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

Australia, New Zealand
King's College London
Biotechnology and Biological Sciences Research Council; Biotherapy Services...

Recruiting

Environmental Factors on DFUs Incidence - a Mixed-mode Survey

Diabetic Foot | Diabetic Foot Ulcer

United Kingdom
Hong Kong Prospect Group Co. Limited
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

A Study to Evaluate the Impact of a Nutritional Product on Cognition in Healthy Teenagers

Healthy

United States
Tangent Data
Stanley Medical Research Institute; MediStat Ltd.; PCI pharma services (formerly... and other collaborators

Unknown

Estradiol as add-on to Antipsychotics (EST-S-02)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders

Moldova, Republic of
Olivia Newton-John Cancer Research Institute
Austin Health; Roche Products Pty Limited; Ballarat Health Services

Active, not recruiting

Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy (FLUORO)

Follicular Lymphoma

Australia
Luke MacNeill
New Brunswick Innovation Foundation; Touchkin eServices Private Limited

Completed

Can Mental Health Chatbots Help Chronic Disease Populations?

Depression | Diabetes | Arthritis | Stress | Anxiety

Canada
Juno Therapeutics, Inc., a Bristol-Myers Squibb...
Bristol-Myers Squibb Services Unlimited Company

Recruiting

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases

Systemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory Myopathy

United States, France, Germany, Italy, Belgium, Spain
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (OZ/DSMCombo)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; Queensland Institute...

Terminated

A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (DSMOZ-2)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

SJ733 Induced Blood Stage Malaria Challenge Study (SJ733IBSMCS)

Plasmodium Falciparum Malaria

Australia
Diurnal Limited
Simbec Research; Brush Clinical Research Ltd.; Voet Consulting; Medical Matters... and other collaborators

Completed

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Adrenal Insufficiency

United Kingdom
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer... and other collaborators

Completed

Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent (OZGAM)

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer... and other collaborators

Completed

Experimental Falciparum Transmission to Anopheles (EFITA)

Malaria

Australia
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological... and other collaborators

Completed

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above (COVID-19)

COVID-19

Jordan, Bahrain, Egypt, United Arab Emirates
Menzies Institute for Medical Research
National Health and Medical Research Council, Australia; National Heart Foundation... and other collaborators

Active, not recruiting

Improved Cardiovascular Disease hEALth Service Delivery in Australia: Cluster Randomised Controlled Trial (IDEAL Study) (IDEAL)

Cardiovascular Diseases

Australia
Kuopio University Hospital
Medical University of Vienna; Rigshospitalet, Denmark; University College, London and other collaborators

Active, not recruiting

Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris (ReGenHeart)

Coronary Artery Disease | Refractory Angina Pectoris | Gene Transfer

Denmark, Finland
Umbria Bioengineering Technologies
Toscana Life Sciences Sviluppo s.r.l.; London South Bank University; ELAROS 24... and other collaborators

Recruiting

A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection

Women's Health: Neoplasm of Breast

Italy, Spain, Poland, Portugal, Switzerland
PATH
London School of Hygiene and Tropical Medicine; Monash University; University... and other collaborators

Not yet recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Opioid Dependence
UNICANCER
Cancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaborators

Not yet recruiting

Personalized Medicine for Advanced Biliary Cancer Patients (SAFIR-ABC10)

Biliary Tract Neoplasms

United Kingdom, France, Belgium
The University of Hong Kong
Hong Kong Young Women's Christian Association; Caritas Medical Centre, Hong... and other collaborators

Recruiting

Collaborative Stepped-Care and Productive Ageing Program for Older People With Depressive Symptoms (JCJoyAge2)

Depressive Symptoms

Hong Kong
PENTA Foundation
Hopital Universitaire Robert-Debre; Cardiff University; Bambino Gesù Hospital... and other collaborators

Terminated

Neonatal Vancomycin Trial (NeoVanc)

Late Onset Neonatal Sepsis

Spain, Italy, United Kingdom, Estonia, Greece
Yaqrit Ltd
Assistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaborators

Withdrawn

Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

France, Italy, Portugal, Spain, Switzerland, United Kingdom
Yaqrit Ltd
Assistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaborators

Terminated

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

Liver Cirrhosis

France, Italy, Portugal, Spain, United Kingdom, Switzerland

Clinical Trials Sponsored by hVIVO Services Limited

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations